InternationalUSRemember you can easily switch between MIP US and MIP International at any time

PTAB 4 Years In: Is the Board too hard on motions to amend?

Michael Loney, New York


The Federal Circuit will soon consider en banc the Patent Trial and Appeal Board’s amendment practice. But, asks Michael Loney, is the 5% success rate of motions to amend unfair on patent owners?

Ahead of the four-year anniversary of PTAB trials being available on September 16 this year, Managing IP is publishing two articles a week revealing 10 issues to watch at the Board. Visit www.managingip.com/ptab to see which other articles have been...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

John Bochnovic, Executive Director of AIPPI, has resigned from the position (effective April 30, 2018) to return to… https://t.co/4dp8lsqg5Z

Feb 16 2018 04:19 ·  reply ·  retweet ·  favourite
ManagingIP profile

CAFC says 101 inquiry is a factual determination in “blockbuster” Berkheimer opinion https://t.co/wpYscoUhnY https://t.co/FPrkImTmGL

Feb 16 2018 03:13 ·  reply ·  retweet ·  favourite
ManagingIP profile

US falls to 12th in US Chamber patent ranking https://t.co/UP7AvAbZ4k Expect to hear this figure mentioned a lot at… https://t.co/gnWLDdISl2

Feb 15 2018 04:45 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


null null null

null null null

February 2018

FRAND aid: Is the European Commission’s SEP guidance useful?

Both patent owners and implementers have welcomed the European Commission’s communication on standard essential patents. Does that mean it has successfully balanced competing interests or merely dodged the difficult questions? James Nurton investigates



Most read articles

Supplements